Antonio Camins
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
A peripheral proteomic signature of Alzheimer's disease is identified in the plasma extracellular vesicles of mild cognitive impairment patients from a memory clinic: the BIOPEXAL study.
Journal: Research square
Published: November 24, 2025
Exosomes-Based Nanomedicine for Neurodegenerative Diseases: Current Insights and Future Challenges.
Journal: Pharmaceutics
Published: December 19, 2022
Extracellular vesicles, the emerging mirrors of brain physiopathology.
Journal: International journal of biological sciences
Published: November 01, 2022
Plasma extracellular vesicles reveal early molecular differences in amyloid positive patients with early-onset mild cognitive impairment.
Journal: Journal of nanobiotechnology
Published: October 19, 2022
Amyloid-β impairs mitochondrial dynamics and autophagy in Alzheimer's disease experimental models.
Journal: Scientific reports
Published: January 18, 2022
Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer's disease: from current to future challenges.
Journal: Journal of nanobiotechnology
Published: January 20, 2021
Epigallocatechin-3-gallate PEGylated poly(lactic-co-glycolic) acid nanoparticles mitigate striatal pathology and motor deficits in 3-nitropropionic acid intoxicated mice.
Journal: Nanomedicine (London, England)
Published: January 07, 2021
State-of-the-art polymeric nanoparticles as promising therapeutic tools against human bacterial infections.
Journal: Journal of nanobiotechnology
Published: July 31, 2020
Current advances in the development of novel polymeric nanoparticles for the treatment of neurodegenerative diseases.
Journal: Nanomedicine (London, England)
Published: May 07, 2020
Benzodiazepines and Related Drugs as a Risk Factor in Alzheimer's Disease Dementia.
Journal: Frontiers in aging neuroscience
Published: June 27, 2019
Neuroprotective Effects of the Amylin Analog, Pramlintide, on Alzheimer's Disease Are Associated with Oxidative Stress Regulation Mechanisms.
Journal: Journal of Alzheimer's disease : JAD
Published: April 09, 2019
Last Updated: 09/26/2026